When a stock makes a strong recovery, it is perhaps time for investors to start paying attention to it. Generic pharmaceutical company Teligent Inc (NASDAQ: TLGT) has managed to recover after having hit a low recently.
The Teligent stock has soared by as high as 20% from its low and could come into the radars of many investors over the coming days. In this regard, it might be a good move for investors to look into an announcement from the company back in February. The company announced that Carter Pate was appointed to the board of directors at Teligent. The company announced that the appointment went into effect immediately.
Teligent went on to add in its press release that Pate is also going to serve in two committees at the company. One of those is Corporate Governance and the other is Audit and Nominating. Investors could do well to keep an eye on the Teligent stock at this point.